An interventional study of Program on a nurse-led telephone 6-month-follow-up for uncontrolled hypertensive women: a patient-tailored intervention in Arterial Hypertension and Medication Nonadherence, sponsored by Mme Edith DAUCHY. Terminated at 1 site in France. Open to female participants aged 18 Years to 79 Years. Per ClinicalTrials.gov, last updated 2026-06-24.
Sponsored by Mme Edith DAUCHY · Not applicable, Interventional, and Other
This study evaluate the feasibility of a 6-month personalized support program for hypertensive and non-observant women, led by nurses by telephone follow-up.
The program includes 2 themes:
Visits :
Inclusion visit :
Implementation of personalized support with the following steps :
Evaluation of the accompaniment:
- assessment at the final visit
6,689 studies on the registry are indexed under Hypertension; 964 are open to participants now.
This study's enrollment of 14 is below the median of 90 across 4,994 interventional studies indexed under Hypertension.
Browse Hypertension studies →This is the only study on the registry with Mme Edith DAUCHY as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Women with uncontrolled hypertension and unsatisfactory medication adherence
Other: Program on a nurse-led telephone 6-month-follow-up for uncontrolled hypertensive women: a patient-tailored intervention
Implementation of personalized support: The accompaniment includes 7 telephone interviews for 6 months (understanding the antihypertensive treatment, identifying the brakes and the levers when taking medication, organizing the treatment taking, making the home blood pressure)
Proportion of women who completed all telephone follow-ups and came to the final visit at 6 months.
The goal of recruitment in 6 months will be 20 women and the goal of the program finalization will be of at least 80% of patients (16 patients).
Time frame: 6 months
Plan to share: No
No publications or documents are linked to this record.
This study is terminated, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.